We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $580M
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+1.14%
1 Year Est. Return
+29.81%
3 Year Est. Return
+39.55%
5 Year Est. Return
-6.93%
10 Year Est. Return
–
AUM
$610M
AUM Growth
+$126M
Cap. Flow
+$157M
Cap. Flow %
25.76%
Top 10 Hldgs %
65.04%
Holding
54
New
16
Increased
19
Reduced
10
Closed
8

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$46.8M
2
WGS icon
GeneDx Holdings
WGS
+$42.7M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$20M
4
ALKS icon
Alkermes
ALKS
+$15.9M
5
PRCT icon
Procept Biorobotics
PRCT
+$15.9M

Top Sells

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$20M
2
FOLD
Amicus Therapeutics
FOLD
+$16.4M
3
SEM
Select Medical
SEM
+$15.4M
4
ROIV icon
Roivant Sciences
ROIV
+$11.5M
5
AVTR icon
Avantor
AVTR
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 99.84%
2 Industrials 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICLR icon
51
Icon
ICLR
$13.1B
– –
-110,000
Closed -$20M
LH icon
52
Labcorp
LH
$27.2B
– –
-34,532
Closed -$8.66M
SEM
53
DELISTED
Select Medical
SEM
– –
-1,035,086
Closed -$15.4M
TEM
54
Tempus AI
TEM
$11.6B
– –
-35,000
Closed -$2.07M
1 2
3

Similar funds

SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
CCWM
Correct Capital Wealth Management Clayton, Missouri $580M AUM 16.45% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
RIS
Retirement Income Solutions Ann Arbor, Michigan $581M AUM 19.42% 1-Year Est. Return
MFS
McNamara Financial Services Marshfield, Massachusetts $580M AUM 17.89% 1-Year Est. Return
GFI
Global Frontier Investments Charleston, South Carolina $581M AUM 8.55% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $579M AUM

Prosight Management's Q1 2026 Portfolio in Review

As of Q1 2026, Prosight Management held 54 positions worth $610M, up 26% from $484M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Prosight Management deployed $157M of net new capital in Q1 2026, opening 16 new positions and adding to 19 existing holdings. Its largest new stake was Alkermes: 513,632 shares worth $18.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Roivant Sciences, an estimated $11.5M trimmed.

  • Prosight Management's largest Q1 2026 buy was Alkermes: 513,632 shares worth $18.2M.
  • Prosight Management added most to Boston Scientific in Q1 2026, an estimated $46.8M increase.
  • Prosight Management's biggest Q1 2026 reduction was Roivant Sciences, cutting an estimated $11.5M.
  • Prosight Management fully exited Icon in Q1 2026, selling an estimated $20M.
  • Prosight Management's ten largest holdings make up 65% of its $610M portfolio in Q1 2026.
  • Prosight Management opened 16 new positions and closed 8 in Q1 2026.
  • Prosight Management's portfolio value rose 26% quarter-over-quarter to $610M.

Based on Prosight Management's 13F filing for Q1 2026, filed 15 May 2026.